---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-393116"
form_type: "8-K"
ticker: "TEVA"
cik: "0000818686"
company_name: "TEVA PHARMACEUTICAL INDUSTRIES LTD"
filed_at: "2026-09-16T20:25:25+00:00"
generated_at: "2026-09-16T20:26:11.260552+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Teva issues €1.5B and $3.2B senior notes; proceeds to redeem existing notes

## Summary
- Issued €1.0B 4.250% notes due 2033 and €0.5B 4.625% notes due 2036.
- Issued $1.0B 5.500% notes due 2034, $1.0B 5.750% notes due 2037, and $1.2B 5.250% notes due 2032.
- Proceeds redeem all 6.750% 2028, 7.875% 2029, 7.375% 2029, and 8.125% 2031 notes; up to $450M of 2027 notes and €1.15B of 2030 notes.
- Remaining proceeds for general corporate purposes; notes guaranteed by Teva on senior unsecured basis.

## SEC filing metadata
- accession: 0001193125-26-393116
- form_type: 8-K
- ticker: TEVA
- cik: 0000818686
- company_name: TEVA PHARMACEUTICAL INDUSTRIES LTD
- filed_at: 2026-09-16T20:25:25+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/818686/000119312526393116/0001193125-26-393116-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/818686/000119312526393116/d155511d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-393116
- JSON: https://secwatch.observer/filing/0001193125-26-393116.json
- Plain text: https://secwatch.observer/filing/0001193125-26-393116.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.